ALL |
acute lymphoblastic leukemia |
AIEOP-BFM ALL |
Associazione Italiana di Ematologia Oncologia Pediatrica-Berlin-Frankfurt-Münster Acute Lymphoblastic Leukemia |
AKT |
serine/threonine kinase |
AML |
acute myeloid leukemia |
ATF4 |
cyclic AMP-dependent transcription factor |
Bad |
Bcl-2-associated agonist of cell death |
Bak |
Bcl-2 homologous antagonist/killer |
Bax |
Bcl-2-associated X-protein 4 |
Bcl-2 |
B-cell lymphoma 2 |
Bcl-w |
B-cell lymphoma-w |
Bcl-XL |
B-cell lymphoma extra-large |
Bid |
BH3 interacting-domain death agonist |
BIM |
Bcl-2-interacting mediator of cell death |
cAMP-PKA |
cyclic adenosine monophosphate-dependent protein kinase |
CASP1 |
caspaze 1 |
CBD |
cannabidiol |
CHOP |
C/EBP Homologous Protein |
CI |
combination index |
CNS |
central nervous system |
CR |
complete response |
CRLF2
|
cytokine receptor-like factor 2 |
dmPGE2 |
6,16-dimethyl-prostaglandin E2 |
DN |
double negative |
DR |
death receptor |
EFS |
event-free survival |
EMA |
European Medicines Agency |
ER |
extreme risk |
ERK |
extracellular signal-regulated kinase |
ESRRB |
orphan nuclear receptor estrogen-related receptor-b |
ETP |
early T-cell progenitor |
FBXW7 |
F-Box and WD Repeat Domain-Containing 7 |
FDA |
Food and Drug Administration |
FKBP51 |
FK506-binding protein 51 |
FOXO3a |
forkhead box O3 |
GR |
glucocorticoid receptor |
GRE |
glucocorticoid response element |
GSK3 |
glycogen synthase kinase-3 |
GTG |
glucocorticoid target gene |
HR |
high risk |
Hrk |
activator of apoptosis harakiri |
HyperCVAD |
hyperfractionated cyclophosphamide, vincristine, doxorubicin, dexamethasone |
IC50
|
half maximal inhibitory concentration |
IGR |
intronic GR binding region |
IL-6 |
interleukin 6 |
IL-7 |
interleukin-7 |
IL-7R |
IL-7 receptor |
JAK |
Janus kinases |
LC50
|
median lethal concentration |
MAPK |
mitogen-activated protein kinase |
Mcl-1 |
induced myeloid leukemia cell differentiation protein |
miRNA |
microRNA |
MLL |
mixed lineage leukemia |
MRD |
minimal residual disease |
mRNA |
messenger RNA |
mTOR |
mammalian target of rapamycin kinase |
NF-κB |
nuclear factor-κB |
NOD |
nonobese diabetic |
Notch |
neurogenic locus notch homolog protein |
Noxa |
phorbol-12-myristate-13-acetate-induced protein 1 |
OXPHOS |
oxidative phosphorylation |
PERK |
protein kinase R -like endoplasmic reticulum kinase |
PGR |
prednisolone good response |
Ph-like |
Philadelphia chromosome-like |
PI3K |
phosphatidylinositol 3-kinase |
PKR |
protein kinase R |
PPR |
prednisolone poor response |
pre-B ALL |
precursor-B-cell ALL |
Puma |
p53-upregulated modulator of apoptosis |
Raf |
rapidly accelerated fibrosarcoma |
Ras |
rat sarcoma virus |
RER |
endoplasmic reticulum |
ROS |
reactive oxygen species |
RT-PCR |
real-time polymerase chain reaction |
SCID |
severe combined immunodeficiency |
SE |
survival estimates |
shRNA |
short hairpin RNA |
SIRT1 |
sirtuin 1 |
SR |
standard risk |
STAT |
signal transducer and activator of transcription |
T-ALL |
precursor T-cell ALL |
T-LL |
T-lymphoblastic lymphoma |
TNF |
tumor-necrosis-factor |
TRB3 |
tribbles homolog 3 |
VDAC |
voltage-dependent anion channel 1 |
VXL |
vincristine, dexamethasone and L-asparaginase |
γc |
γ chain |
Δ9-THC |
Δ9-tetrahydrocannabinol |